Replies to post #160459 on Biotech Values

[jbog]

jq,

I'm sure rebif and avonex patients are included, but to a lesser degree because of their dosing schedule. The initial group being transferred to bg-12 are patients who the neuro's know don't behave correctly and routinely skip their daily injections.